FDA: Class I recall of GlideScope Titanium Single-Use Video Laryngoscope
Editor's Note
The Food and Drug Administration (FDA) on March 18 announced the Class I recall of the GlideScope Titanium Single-Use Video Laryngoscope by Verathon (Bothell, Washington). Class I is the most serious.
The recall was initiated because of a potential disruption in the video feed from the laryngoscope blade camera to the monitor. A disrupted or unstable video image may lead to delayed tracheal tube insertion, intubation failure, and other serious adverse events.
Posted 03/18/2016] AUDIENCE: Risk Manager, Otolaryngology, Anesthesiology ISSUE: Verathon Incorporated is recalling the GlideScope Titanium Single-Use Video Laryngoscope because of a potential disruption in the video feed from the camera in the laryngoscope blades to the monitor.
Read More >>
Free Daily News
- HCA Healthcare reports solid first-quarter financials
- Per-person healthcare spending grows nearly 19% in 5 years
- OR Manager Conference: Lowest rates expire in one week
- Hospitals boost cybersecurity budgets, staff
- Kentucky passes first-ever state law decriminalizing medical mistakes
- Kaiser Permanente data breach affects 13.4 million
- Study explores link between diverticulitis and colorectal cancer
- State lawmakers target rising healthcare costs via legislation on hospital facility fees
- FDA medical device Class 1 recalls trend upward
- Data cast doubt on recommendation to delay weight-loss meds prior to surgery